Semaglutide vs. Tirzepatide: Which GLP-1 Medication Is Right for You?
Both medications have transformed weight loss treatment, but they work differently. Here's what the clinical evidence shows and how to choose between them.
How Do These Medications Work?
GLP-1 receptor agonists mimic a natural hormone your body produces after eating. This hormone signals fullness to your brain, slows gastric emptying, and helps regulate blood sugar. The result is a dramatic reduction in appetite and what patients describe as the elimination of "food noise" — the constant mental chatter about eating.
Semaglutide (brand names: Wegovy for weight loss, Ozempic for diabetes) targets the GLP-1 receptor. It was approved by the FDA for chronic weight management in June 2021 based on the landmark STEP clinical trial program.
Tirzepatide (brand names: Zepbound for weight loss, Mounjaro for diabetes) targets both the GLP-1 and GIP receptors — a dual-action mechanism. It was approved for weight management in November 2023 based on the SURMOUNT trial program. The dual receptor action may explain why tirzepatide tends to produce greater weight loss in clinical trials.
Clinical Trial Results: Head-to-Head Comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| Key trial | STEP 1 (NEJM, 2021) | SURMOUNT-1 (NEJM, 2022) |
| Average weight loss | 14.9–16.9% of body weight | 15.0–22.5% of body weight |
| Patients losing ≥20% | ~32% at highest dose | ~57% at highest dose |
| Dosing | Weekly injection | Weekly injection |
| FDA approved for weight loss | June 2021 (Wegovy) | November 2023 (Zepbound) |
| Starting dose | 0.25 mg/week | 2.5 mg/week |
| Max dose | 2.4 mg/week | 15 mg/week |
| Also treats diabetes | Yes (as Ozempic) | Yes (as Mounjaro) |
| Cost at New Hope | From $166/month | From $233/month |
What Does the Weight Loss Look Like Month by Month?
Both medications follow a dose-titration schedule where you start at a low dose and gradually increase. This minimizes side effects while building toward the therapeutic dose.
Semaglutide typical timeline
Month 1–2: Starting dose (0.25 mg). Most patients lose 3–5 lbs. Appetite begins to decrease. Some GI adjustment. Month 3–4: Dose increases to 0.5–1.0 mg. Weight loss accelerates to 1–2 lbs/week. "Food noise" diminishes significantly. Month 5–8: Therapeutic dose (1.7–2.4 mg). Steady 1–2 lbs/week. Most patients report dramatically reduced cravings. Month 9–12+: Many patients approach 15% total body weight loss. Dose may be maintained or adjusted.
Tirzepatide typical timeline
Month 1–2: Starting dose (2.5 mg). Similar early weight loss of 3–6 lbs. Dual mechanism begins working. Month 3–4: Dose increases to 5–7.5 mg. Weight loss accelerates, often faster than semaglutide at this stage. Month 5–8: Therapeutic dose (10–15 mg). Strong weight loss of 2+ lbs/week for many patients. Month 9–12+: Patients at highest dose may approach 20%+ total body weight loss.
Side Effects: What to Expect
Both medications share a similar side effect profile, primarily gastrointestinal, and these effects typically decrease over time as your body adjusts and your dose stabilizes.
Common side effects (both): nausea (most common, especially at dose increases), diarrhea, constipation, vomiting, abdominal pain, and decreased appetite. These affect 30–50% of patients at some point during treatment, with most experiencing improvement within 2–4 weeks.
Less common: injection site reactions, headache, fatigue, dizziness, and heartburn.
Who Qualifies for GLP-1 Medication?
The FDA has approved both medications for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Your physician at New Hope Weight Loss evaluates your complete medical history to determine eligibility.
Which Medication Should You Choose?
Consider semaglutide if: you want the most clinically established GLP-1 option with the longest track record, you prefer a lower monthly cost (from $166/mo at New Hope Weight Loss), your weight loss goal is moderate (15–20% of body weight), or you have type 2 diabetes and want the dual benefit.
Consider tirzepatide if: you want the potential for greater weight loss (20%+ of body weight), you have significant weight to lose, you've tried semaglutide with limited results, or you have type 2 diabetes that's difficult to control with other medications.
The best choice is the one your physician recommends based on your medical history, goals, other medications, and insurance or budget considerations. At New Hope Weight Loss, your doctor evaluates all of these factors during the initial consultation.
Frequently Asked Questions
Which is more effective for weight loss, semaglutide or tirzepatide?
Clinical trials show tirzepatide produces greater average weight loss — up to 22.5% of body weight in the SURMOUNT-1 trial compared to up to 16.9% for semaglutide in STEP 1. However, individual results vary significantly. Some patients respond better to semaglutide. Your physician will recommend the best option based on your specific health profile and goals.
How much does semaglutide cost vs. tirzepatide at New Hope Weight Loss?
At New Hope Weight Loss in Costa Mesa, CA, semaglutide programs start at $166 per month and tirzepatide programs start at $233 per month. The initial doctor review and prescription fee is $119 for either medication — medication costs are billed separately. We accept HSA and FSA payments.
Can I switch from semaglutide to tirzepatide?
Yes. Switching between GLP-1 medications is a common clinical decision made under physician supervision. If you've plateaued on semaglutide or want to explore tirzepatide's dual mechanism, your doctor can develop a safe transition plan.
What are the main side effects?
Both medications share similar gastrointestinal side effects including nausea, diarrhea, vomiting, and constipation. These are typically most noticeable during dose increases and improve within 2–4 weeks. Both carry an FDA boxed warning about thyroid C-cell tumors. Your physician monitors for side effects and adjusts dosing throughout treatment.
Do I need a prescription?
Yes. Both semaglutide and tirzepatide are prescription-only medications requiring physician evaluation. At New Hope Weight Loss, the doctor review is $119. If you are not approved for treatment, you are not charged for medication.
How long do I need to take GLP-1 medication?
Most patients see significant results within the first 90 days of treatment. The major clinical trials ran 68–72 weeks. Many patients transition to lower maintenance doses after reaching their goal weight. Your physician will create a personalized treatment plan and adjust it based on your progress.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results may vary. GLP-1 medications require a prescription and physician supervision. All medical claims are based on published clinical trial data from the STEP and SURMOUNT programs. Consult your healthcare provider before starting any weight loss medication.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded medications are not FDA-approved products.